ZEISS Introduces ALTA DUO 300
In a significant advancement for eye care practices, ZEISS Medical Technology has unveiled the
ZEISS ALTA DUO 300, a fully automated multimodal imaging solution specifically designed for retinal assessments. The new device integrates both Optical Coherence Tomography (OCT) and fundus photography within a single, compact unit, enhancing the capabilities of eye care professionals while addressing diverse clinical needs.
A Comprehensive Imaging Solution
The ALTA DUO 300 represents a pivotal addition to ZEISS's expansive retinal imaging portfolio. By combining these two key modalities into a single device, the ZEISS ALTA DUO 300 enables eye care providers to conduct comprehensive assessments efficiently. This innovation is expected to facilitate a smoother workflow, improving patient care in various settings. According to
Andreas Völker, Head of the Ophthalmology Strategic Business Unit at ZEISS Medical Technology, this new product adds significant value to their offerings, allowing practitioners to better serve their patients.
Features and Benefits
One of the standout features of the ZEISS ALTA DUO 300 is its fully automated operation, providing consistency and ease of use. It includes advanced capabilities such as:
- - Fully Automated Structural OCT: This feature comes with a robust reference database and comprehensive reporting tools, minimizing manual input and potential errors.
- - True Color Fundus Photography: Enables clear imaging of the retina, crucial for accurate diagnostics.
- - AI-Enhanced OCT-Angiography: High-resolution imaging that aids in the detailed analysis of retinal blood flow and conditions.
- - Anterior Chamber Depth Scans: The device allows comprehensive scans without the need for external lenses, making it simpler to use in various clinical situations.
Eye care professionals often face challenges in integrating advanced imaging into their routine practices. The ZEISS ALTA DUO 300 addresses these concerns by offering a streamlined solution that optimizes both efficiency and accessibility.
Launch and Availability
Scheduled for display at the
European Society of Retina Specialists (EURETINA) congress in Vienna, Austria, from
October 1-4, 2026, the ALTA DUO 300 is set to be available in select markets later that year. This presentation is expected to draw significant attention from industry professionals eager to explore its capabilities firsthand.
The Future of Retinal Imaging
The launch of the ZEISS ALTA DUO 300 is not just about a new product; it symbolizes ZEISS’s commitment to advancing ophthalmology through innovative technology.
Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology, notes that many practices seek ways to incorporate retinal imaging seamlessly into everyday care. The ALTA DUO will help clinics meet this goal by offering consistent and reliable imaging solutions tailored to various patient needs.
As the demand for efficient and effective eye care solutions grows, the ALTA DUO 300 positions ZEISS at the forefront of retinal imaging technology, ready to support eye care professionals in delivering the highest quality of patient care. For more information and to see the device in action, visit the
ZEISS booth B50 in Hall B during the EURETINA congress.
In conclusion, the ZEISS ALTA DUO 300 not only enhances imaging capabilities but also enables eye care providers to deliver superior service and care. This innovation is a remarkable step forward in retinal diagnostics, promising to change the landscape of how eye care is practiced worldwide.